Krishna Inst of MED SCI L
NSE: KIMS · Hospital · sector
₹669.60NSE close 2026-10-26
Key numbers
Market cap₹28,123 cr
Price₹669.60
52w high / low₹858 / ₹576
P/E131.3xSector median 42.5x
P/B12.5xSector median 4.9x
Book value₹53.5
Dividend yield0.74%Sector median 0.17%
ROE9.3%Sector median 12.1%
ROCE9.6%Sector median 13.8%
OPM19.5%Sector median 20.3%
Debt / equity1.44xSector median 0.24x
EV/EBITDA38.1xSector median 23.6x
Interest cover2.1x
Current ratio0.76x
Sales growth 3y+21.1%Sector median +14.1%
Profit growth 3y-10.5%Sector median +14.7%
PEG–
Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 32 companies in Hospital (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹90 cr vs borrowings ₹3,244 cr (FY26): borrowings are higher by ₹3,154 cr.
- Borrowings rose in each of the last 3 years (₹678 cr → ₹3,244 cr).
- Operating profit covered interest 2.1x in the last 12 months.
- 11.71% of the promoters' shares are pledged (3.8% of all shares).
- Promoter holding fell by 1.45 percentage points in a year, to 32.66% (2026-09-30).
- Operating cash flow was below net profit in 0 of the last 5 years.
- Revenue was higher than a year earlier in 4 of the last 4 quarters.
- Other income was 17% of net profit in the last 12 months.
- No dividend in the last 5 financial years.
- Price ₹669.60 on 2026-10-26: -22.0% from the 52-week high, +16.3% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Weekly close · high ₹831.00 · low ₹513.65
RevenueNet profit
RevenueNet profit
Quarterly results
| ₹ cr | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 777 | 772 | 797 | 872 | 961 | 998 | 1,075 | 1,180 |
| EBITDA | 218 | 187 | 209 | 193 | 204 | 199 | 196 | 223 |
| OPM % | 28.1% | 24.2% | 26.2% | 22.1% | 21.2% | 19.9% | 18.2% | 18.9% |
| Other income | 5 | 18 | 4 | 7 | 4 | 5 | 10 | 16 |
| Net profit | 107 | 92 | 102 | 79 | 67 | 53 | 42 | 42 |
| EPS (₹) | 2.68 | 2.22 | 2.54 | 1.96 | 1.67 | 1.33 | 1.06 | 1.04 |
| Revenue YoY | +23.6% | +29.2% | +34.8% | +35.3% | ||||
| Profit YoY | -37.5% | -42.3% | -58.3% | -47.2% |
Consolidated figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 1,651 | 2,198 | 2,498 | 3,035 | 3,905 | 4,212 |
| EBITDA | 516 | 619 | 640 | 794 | 791 | 822 |
| Net profit | 333 | 336 | 310 | 384 | 241 | 204 |
| EPS (₹) | 8.38 | 8.41 | 7.75 | 9.61 | 6.03 | 5.10 |
| Revenue growth | +33.1% | +13.7% | +21.5% | +28.6% | +30.9% | |
| Profit growth | +1.1% | -7.8% | +24.0% | -37.2% | -46.2% | |
| Dividend / share (₹) | – | – | – | – | – |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | +21.1% | +24.0% | +30.9% |
| Net profit | -10.5% | +3.7% | -46.2% |
| EPS | -10.5% | +2.3% | – |
| Share price | – | +11.2% (2y) | -7.3% |
Balance sheet
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Shareholders' equity | – | 1,670 | 1,828 | 2,138 | 2,247 |
| Borrowings | – | 678 | 1,355 | 2,557 | 3,244 |
| Cash & equivalents | – | 134 | 132 | 102 | 90 |
| Total assets | – | 2,941 | 3,852 | 5,736 | 7,759 |
| Fixed assets | – | 1,381 | 1,730 | 2,199 | 4,186 |
| Capital work in progress | – | 477 | 600 | 1,214 | 606 |
| Investments | – | 0 | 74 | 1 | 1 |
| Receivables | – | 253 | 294 | 395 | 554 |
| Inventory | – | 43 | 49 | 64 | 97 |
| Payables | – | 174 | 197 | 269 | 323 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash from operations | 520 | 432 | 521 | 582 | 511 |
| Cash from investing | -606 | -616 | -753 | -1,116 | -1,452 |
| Cash from financing | 60 | 88 | 217 | 543 | 940 |
| Capex | 170 | 575 | 647 | 1,009 | 1,428 |
| Free cash flow | 350 | -142 | -126 | -427 | -917 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| ROE % | – | 20.1% | 17.0% | 18.0% | 10.7% |
| ROCE % | – | 22.0% | 15.9% | 13.8% | 9.7% |
| Debtor days | – | 42 | 43 | 48 | 52 |
| Inventory days | – | 33 | 34 | 37 | 44 |
| Payable days | – | 132 | 136 | 157 | 146 |
| Cash conversion cycle (days) | – | -57 | -59 | -72 | -50 |
| Working capital days | – | 30 | 21 | -17 | -28 |
Shareholding
| Holder | % (2026-09-30) |
|---|---|
| Promoters | 32.66% |
| FIIs | 15.01% |
| DIIs | 33.22% |
| of which Mutual funds | 28.21% |
| of which Insurance | 4.09% |
| Public (non-institutions) | 19.11% |
| Quarter | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters % | 38.82% | 34.11% | 34.11% | 34.11% | 34.11% | 32.50% | 32.50% | 32.66% |
| Promoter group | % |
|---|---|
| Bhaskara Rao Bollineni | 25.02% |
| Bluebridge Capital Private Limited | 5.76% |
| Rajyasri Bollineni | 1.64% |
| Bharas Ventures Llp | 0.16% |
| Abhinay Bollineni | 0.06% |
| Adwik Bollineni | 0.01% |
| Sweata Raavi | 0.01% |
| Public holders above 1% | % |
|---|---|
| Sbi Small Cap Fund | 4.85% |
| Axis Mutual Fund Trustee Limited A/C Axis Mutual Fund A/C Axis Small Cap Fund | 4.76% |
| Kotak Small Cap Fund | 4.42% |
| Hdfc Small Cap Fund | 3.99% |
| Bollineni Seenaiah Naidu | 3.93% |
| Invesco India Flexi Cap Fund | 3.57% |
| Amansa Holdings Private Limited | 2.15% |
| Lilac Investments Limited | 1.87% |
| Nippon Life India Trustee Ltd-A/C Nippon India Small Cap Fund | 1.79% |
| Sbi Life Insurance Co. Ltd | 1.71% |
| Nomura India Investment Fund Mother Fund | 1.42% |
| Hdfc Life Insurance Company Limited | 1.26% |
| Polar Capital Funds Plc - Healthcare Opportunities Fund | 1.23% |
| Venkata Krishna Kumar Kodali | 1.20% |
95,609 shareholders. Pledged: 11.71% of promoter shares.
Peers in Hospital
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| APOLLOHOSP | ₹1,12,797 cr | 54.0x | 11.9x | 23.6% | 21.8% | 15.1% | +14.9% | 0.26% |
| MAXHEALTH | ₹81,266 cr | 55.7x | 7.6x | 14.5% | 13.8% | 26.1% | +22.4% | 0.18% |
| MANIPALHOS | ₹73,581 cr | – | – | – | – | – | – | – |
| FORTIS | ₹55,467 cr | 52.9x | 5.6x | 11.1% | 13.2% | 22.2% | +13.2% | 0.14% |
| NH | ₹33,971 cr | 41.4x | 7.5x | 20.0% | 13.7% | 18.7% | +20.4% | 0.26% |
| ASTERDM | ₹33,523 cr | 104.7x | 7.3x | 8.0% | 12.8% | 16.7% | -27.0% | 0.16% |
| MEDANTA | ₹32,575 cr | 58.5x | 8.2x | 15.1% | 15.8% | 20.5% | +17.9% | 0.04% |
| KIMS | ₹28,123 cr | 131.3x | 12.5x | 9.3% | 9.6% | 19.5% | +21.1% | 0.74% |
| AGARWALEYE | ₹15,065 cr | 101.3x | 7.4x | 7.6% | 16.5% | 27.8% | – | 0.01% |
| RAINBOW | ₹11,802 cr | 41.3x | 7.2x | 18.3% | 27.4% | 31.5% | +13.2% | 0.26% |
Dividends & corporate actions
| Ex-date | Action | Detail |
|---|---|---|
| 2024-09-13 | Split | Face Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 2/- Per Share |
Documents
- Annual report FY26
- Annual report FY25
- Annual report FY24
- Annual report FY23
- Annual report FY22
- Announcements NSE filings
- BRSR FY26
- Latest results (data file) XBRL
- Announcements BSE filings
Links go to the original files on the exchange website.
About the company
- Hospital and Medical Care: Hospital Activities
| Sector | Healthcare |
| Industry | Hospital |
| Sub-industry | Hospital |
| Symbol | KIMS |
| BSE code | 543308 |
| ISIN | INE967H01025 |
| Face value | ₹2.0 |
| Incorporated | 1973-07-26 |
| Website | www.kimshospitals.com |
| Plants (India / abroad) | 6 / 0 |
From the company's filings (BRSR FY26).
Data built 2026-10-22 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.